Cargando…
Nuclear TFE3 expression is a diagnostic marker for Desmoid-type fibromatosis
BACKGROUND: Desmoid-type fibromatosis (DTF) is a lesion characterized by clonal proliferation of myofibroblasts, which exhibits an infiltrative growth pattern. It is necessary for them to be distinguished from other fibroblastic and myofibroblastic lesions as well as spindle cell tumors. Altered Wnt...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6495536/ https://www.ncbi.nlm.nih.gov/pubmed/31043173 http://dx.doi.org/10.1186/s13000-019-0814-4 |
_version_ | 1783415361952022528 |
---|---|
author | Zhou, Luting Xu, Haimin Zhou, Jun Dong, Lei Zhang, Peipei Yang, Xiaoqun Wang, Chaofu |
author_facet | Zhou, Luting Xu, Haimin Zhou, Jun Dong, Lei Zhang, Peipei Yang, Xiaoqun Wang, Chaofu |
author_sort | Zhou, Luting |
collection | PubMed |
description | BACKGROUND: Desmoid-type fibromatosis (DTF) is a lesion characterized by clonal proliferation of myofibroblasts, which exhibits an infiltrative growth pattern. It is necessary for them to be distinguished from other fibroblastic and myofibroblastic lesions as well as spindle cell tumors. Altered Wnt signaling can act as a defining characteristic of DTF, with nuclear β-catenin serving as a diagnostic marker for. Transcription factor E3 (TFE3) has been linked to Wnt pathway activation and regulation, and may add value to the diagnosis of DTF. The present study, therefore, sought to assess whether TFE3 is a specific diagnostic marker for DTF. METHODS: Nuclear TFE3 and β-catenin staining was performed on a wide range of tumor types such as DTF (n = 46), nodular fasciitis (n = 14), neurofibroma (n = 5), dermatofibrosarcoma protuberans (n = 5), gastrointestinal stromal tumor (n = 10), sclerosing epithelioid fibrosarcoma (n = 2), synovial sarcoma (n = 5), leiomyoma (n = 3) and cutaneous scar tissue (n = 4) using an immunohistochemical approach. In addition, the clinicopathological features and localization of these tumors were summarized. FISH assay was carried out to examine Xp11.2 translocations/TFE3 gene fusions. Statistical difference between immunohistochemical expression of TFE3 and β-catenin was analyzed. RESULTS: The expression of nuclear TFE3 protein was found in 43 (93.5%) DTF tissue samples, ranging from moderate to intense expression levels. The distribution rates of TFE3 positivity in nodular fasciitis, gastrointestinal stromal tumor, leiomyoma and scar tissue samples were 42.9, 40, 25 and 33%, respectively. All studied samples of neurofibroma, synovial sarcoma, sclerosing epithelioid fibrosarcoma and dermatofibrosarcoma protuberans were negative for TFE3. CONCLUSIONS: This study reveal that TFE3 has a potential to serve as a diagnostic marker capable of assisting in the differential diagnosis of DTF and other spindle cell lesions. |
format | Online Article Text |
id | pubmed-6495536 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-64955362019-05-08 Nuclear TFE3 expression is a diagnostic marker for Desmoid-type fibromatosis Zhou, Luting Xu, Haimin Zhou, Jun Dong, Lei Zhang, Peipei Yang, Xiaoqun Wang, Chaofu Diagn Pathol Research BACKGROUND: Desmoid-type fibromatosis (DTF) is a lesion characterized by clonal proliferation of myofibroblasts, which exhibits an infiltrative growth pattern. It is necessary for them to be distinguished from other fibroblastic and myofibroblastic lesions as well as spindle cell tumors. Altered Wnt signaling can act as a defining characteristic of DTF, with nuclear β-catenin serving as a diagnostic marker for. Transcription factor E3 (TFE3) has been linked to Wnt pathway activation and regulation, and may add value to the diagnosis of DTF. The present study, therefore, sought to assess whether TFE3 is a specific diagnostic marker for DTF. METHODS: Nuclear TFE3 and β-catenin staining was performed on a wide range of tumor types such as DTF (n = 46), nodular fasciitis (n = 14), neurofibroma (n = 5), dermatofibrosarcoma protuberans (n = 5), gastrointestinal stromal tumor (n = 10), sclerosing epithelioid fibrosarcoma (n = 2), synovial sarcoma (n = 5), leiomyoma (n = 3) and cutaneous scar tissue (n = 4) using an immunohistochemical approach. In addition, the clinicopathological features and localization of these tumors were summarized. FISH assay was carried out to examine Xp11.2 translocations/TFE3 gene fusions. Statistical difference between immunohistochemical expression of TFE3 and β-catenin was analyzed. RESULTS: The expression of nuclear TFE3 protein was found in 43 (93.5%) DTF tissue samples, ranging from moderate to intense expression levels. The distribution rates of TFE3 positivity in nodular fasciitis, gastrointestinal stromal tumor, leiomyoma and scar tissue samples were 42.9, 40, 25 and 33%, respectively. All studied samples of neurofibroma, synovial sarcoma, sclerosing epithelioid fibrosarcoma and dermatofibrosarcoma protuberans were negative for TFE3. CONCLUSIONS: This study reveal that TFE3 has a potential to serve as a diagnostic marker capable of assisting in the differential diagnosis of DTF and other spindle cell lesions. BioMed Central 2019-05-01 /pmc/articles/PMC6495536/ /pubmed/31043173 http://dx.doi.org/10.1186/s13000-019-0814-4 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Zhou, Luting Xu, Haimin Zhou, Jun Dong, Lei Zhang, Peipei Yang, Xiaoqun Wang, Chaofu Nuclear TFE3 expression is a diagnostic marker for Desmoid-type fibromatosis |
title | Nuclear TFE3 expression is a diagnostic marker for Desmoid-type fibromatosis |
title_full | Nuclear TFE3 expression is a diagnostic marker for Desmoid-type fibromatosis |
title_fullStr | Nuclear TFE3 expression is a diagnostic marker for Desmoid-type fibromatosis |
title_full_unstemmed | Nuclear TFE3 expression is a diagnostic marker for Desmoid-type fibromatosis |
title_short | Nuclear TFE3 expression is a diagnostic marker for Desmoid-type fibromatosis |
title_sort | nuclear tfe3 expression is a diagnostic marker for desmoid-type fibromatosis |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6495536/ https://www.ncbi.nlm.nih.gov/pubmed/31043173 http://dx.doi.org/10.1186/s13000-019-0814-4 |
work_keys_str_mv | AT zhouluting nucleartfe3expressionisadiagnosticmarkerfordesmoidtypefibromatosis AT xuhaimin nucleartfe3expressionisadiagnosticmarkerfordesmoidtypefibromatosis AT zhoujun nucleartfe3expressionisadiagnosticmarkerfordesmoidtypefibromatosis AT donglei nucleartfe3expressionisadiagnosticmarkerfordesmoidtypefibromatosis AT zhangpeipei nucleartfe3expressionisadiagnosticmarkerfordesmoidtypefibromatosis AT yangxiaoqun nucleartfe3expressionisadiagnosticmarkerfordesmoidtypefibromatosis AT wangchaofu nucleartfe3expressionisadiagnosticmarkerfordesmoidtypefibromatosis |